CJC-1295 vs Tesamorelin
CJC-1295 and Tesamorelin are both peptide compounds evaluated on Vial: CJC-1295 is available as a compounded preparation with clinical-trial evidence, and Tesamorelin is available as a compounded preparation with clinical-trial evidence, offered by 16 and 3 verified providers respectively.
Vial summary · compiled from public records
At a glance
Tesamorelin
Sold as Egrifta
- Category
- Peptide
- FDA / legal status
- Compoundable
- Route
- Subcutaneous
Side by side
| Field | CJC-1295 | Tesamorelin |
|---|---|---|
| Category | Peptide | Peptide |
| Brand names | — | Egrifta |
| FDA / legal status | Compoundable | Compoundable |
| Evidence tier | Clinical Trials | Clinical Trials |
| Administration route | Subcutaneous | Subcutaneous |
| Compounding access | Available through 503A and 503B compounding pharmacies | Available through 503A and 503B compounding pharmacies |
| Providers on Vial | 16 listed | 3 listed |
| Typical price band | $$ to $$$ | $$ to $$$ |
Verified providers offering each
Ranked by Confidence Rating, Vial’s 0 to 100 score built from federal and state public records. The score evaluates the provider, not the compound.
About each compound
About CJC-1295
A synthetic analog of growth hormone-releasing hormone (GHRH), this 30-amino acid peptide is modified with a drug affinity complex (DAC) that extends its half-life by binding to serum albumin. It stimulates pulsatile growth hormone secretion from the anterior pituitary by activating GHRH receptors. The compound has been investigated in clinical research for growth hormone deficiency and conditions associated with impaired GH/IGF-1 axis function.
About Tesamorelin
Tesamorelin is an FDA-approved GHRH analog indicated for HIV-associated lipodystrophy and is used off-label in optimization medicine for visceral fat reduction and cognitive enhancement. Clinical data shows significant reductions in visceral adipose tissue and emerging evidence suggests neuroprotective benefits in older adults. It produces stronger and more sustained GH elevation than sermorelin. Compounded versions are available through licensed pharmacies.
Descriptions compiled from public FDA records and manufacturer labeling where available. Not medical advice.
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.
Related compound comparisons
Other comparisons in the same category.